Lombard Odier Asset Management (Switzerland)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,538
Closed -$1.74M 279
2022
Q2
$1.74M Sell
16,538
-48,462
-75% -$6.19M 0.15% 122
2022
Q1
$11.2M Buy
+65,000
New +$9.71M 0.88% 43
2016
Q4
Sell
-140,000
Closed -$6.64M 95
2016
Q3
$6.64M Buy
140,000
+32,215
+30% +$1.61M 1.59% 22
2016
Q2
$5.44M Buy
+107,785
New +$5.44M 0.74% 32

Other funds holding AMED

Lombard Odier Asset Management (Switzerland)'s AMED Position: Q3 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of Amedisys (AMED) in Q3 2022, closing a stake of 16,538 shares — an estimated $1.74M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in AMED in Q2 2016 and held it in 4 quarters. The position peaked at $11.2M in Q1 2022. 287 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 16,538 Amedisys shares in Q3 2022, an estimated $1.74M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Amedisys in Q2 2016 and held it in 4 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Amedisys position peaked at $11.2M in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.